Viloxazine, sold under the brand name Qelbree and formerly as Vivalan among others, is a selective norepinephrine reuptake inhibitor medication which is...
36 KB (3,053 words) - 10:36, 12 January 2024
inhibitors Marketed Atomoxetine (Strattera) Reboxetine (Edronax, Vestra) Viloxazine (Qelbree, Vivalan) Never marketed Amedalin (UK-3540-1) Daledalin (UK-3557-15)...
7 KB (627 words) - 19:38, 15 February 2024
Maprotiline Medifoxamine Mianserin Nomifensine Tianeptine Trazodone Venlafaxine Viloxazine Atypical antidepressant Development and discovery of SSRI drugs Pharmacology...
3 KB (236 words) - 06:12, 1 January 2022
off-label to treat ADHD. Two non-stimulant medications, atomoxetine and viloxazine, are approved by the FDA and in other countries for the treatment of ADHD...
252 KB (26,970 words) - 04:42, 6 June 2024
Teniloxazine (Lucelan, Metatone) – also a 5-HT2A receptor antagonist Viloxazine (Qelbree, formerly Vivalan) – also a 5-HT2B receptor antagonist and 5-HT2C...
16 KB (1,411 words) - 22:41, 3 April 2024
Mazindol Nisoxetine Reboxetine Talopram Talsupram Tandamine Teniloxazine Viloxazine Norepinephrine–dopamine reuptake inhibitors: Amineptine Bupropion Fencamine...
118 KB (11,403 words) - 06:45, 15 May 2024
NRIsTooltip Norepinephrine reuptake inhibitors Atomoxetine Reboxetine Viloxazine NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors Amineptine‡ Bupropion...
190 KB (20,467 words) - 01:48, 25 May 2024
(+dexmethylphenidate) Non-classical CNS stimulants Armodafinil Atomoxetine Modafinil Viloxazine α2-adrenoceptor agonists Clonidine Guanfacine Antidepressants Amitriptyline...
150 KB (14,837 words) - 07:56, 26 May 2024
Mazindol Nisoxetine Reboxetine Talopram Talsupram Tandamine Teniloxazine Viloxazine Norepinephrine–dopamine reuptake inhibitors: Amineptine Bupropion Fencamine...
162 KB (17,679 words) - 23:29, 22 May 2024
NRIsTooltip Norepinephrine reuptake inhibitors Atomoxetine Reboxetine Viloxazine NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors Amineptine‡ Bupropion...
3 KB (290 words) - 00:06, 11 March 2024